We examined the differentiation activity of retinoyl p-D-glucuronide, a biologically active physiological metabolite of vitamin A, using the human promyelocytic leukemic cell line HL-60, which can be induced to differentiate with retinoic acid. Retinoyl /3-D-glucuronide (1 ,AM) inhibited HL-60 cell proliferation by 55-75%, inhibited tritiated thymidine incorporation into DNA by 63-80%, and induced 38-50% of the cells to differentiate into mature granulocytes. The potency of growth inhibition and induction of differentiation by retinoyl .8-D-glucuronide was similar to that of all-trans-retinoic acid. The continuous presence of either retinoyl .l-Dglucuronide or all-trans-retinoic acid was not required to obtain maximum growth arrest and differentiation: a 1-hr exposure of HL-60 cells to the retinoids gave the same response (measured after a total incubation time of 48 hr) as a 24-hr or 48-hr continuous treatment. Retinoyl j3-D-glucuronide (0.1-0.2 mM) was 50% less cytotoxic to HL-60 cells than all-trans-retinoic acid at an equimolar concentration. Retinoyl P-D-glucuronide was not significantly metabolized to other retinoids; retinoic acid was not formed during incubation. We conclude that retinoyl ,8-D-glucuronide can arrest HL-60 cell proliferation and induce their differentiation into mature granulocytes; it may act by itself or by being hydrolyzed to retinoic acid, which could be immediately utilized and metabolized. The therapeutic use of this retinoid as an antineoplastic agent is suggested.
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Vitamin A is an essential micronutrient involved in normal proliferation and differentiation of cells of mesodermal, endodermal, and ectodermal origin (1) (2) (3) (4) . Vitamin A compounds, their biologically active metabolites, and their synthetic derivatives, collectively called retinoids, are also potent anticarcinogenic agents in many experimental models: they suppress or delay the process of carcinogenesis in vivo and in vitro. In many in vitro systems vitamin A active compounds inhibit growth of transformed neoplastic cells and induce their differentiation and maturation (2) (3) (4) (5) .
Vitamin A compounds are involved in normal and abnormal hemopoiesis (12) . Acute myeloid leukemia is attributed to the propagation of a clone of cells that have a block in their differentiation pathway to functional mature granulocytes or monocytes. The human cell line HL-60, developed by Collins et al. (6) , has been extensively used to examine compounds that might induce maturation of these cells and that might be used clinically. Breitman et al. (7, 8) demonstrated that retinoic acid inhibits proliferation of HL-60 cells and induces them to differentiate into morphologically functional mature granulocytes. This finding has been substantiated in other laboratories (9) (10) (11) (12) (13) (14) . The well-established anticarcinogenic effect of retinoids in experimental systems has suggested a potential for clinical use of retinoids as cancer preventive or chemotherapeutic agents. Retinoic acid is among the more promising candidates for successful clinical application (5, 9, 15, 16) . Treatment of leukemia patients with retinoic acid has resulted in an increased number of maturing bone marrow cells and myeloid cells in the peripheral blood of the patients (17) (18) (19) . However, clinical usefulness of retinoids as antineoplastic agents is limited, due to their toxicity and teratogenicity at the relatively high concentrations that are required for their effectiveness in chemotherapy (20, 21) . It is, therefore, important to search for antineoplastic agents with properties more suited for clinical use.
We report here for the first time that retinoyl P3-D-glucuronide, a biologically active glucuronic acid conjugate of retinoic acid, inhibits proliferation of promyelocytic leukemia HL-60 cells and induces their terminal differentiation into mature granulocytes. While the antineoplastic biopotency of retinoyl glucuronide in this system was similar to that of the free retinoic acid, this physiologically active metabolite of vitamin A is water soluble and is less cytotoxic. 25 Ci/mmol; 1 Ci = 37 GBq) was purchased from Amersham. Nitroblue tetrazolium was purchased from Sigma. Phorbol 12,13-dimyristate was obtained from P-L Biochemicals. Saccharo-1,4-lactone monhydrate was obtained from Calbiochem-Behring. Calf serum was purchased from HyClone (Logan, UT); RPMI 1640 medium and horse serum were obtained from GIBCO. fl-D-Glucuronidase (bovine liver), phenolphthalein glucuronide, and free phenolphthalein were obtained from Worthington. All other chemicals were from Sigma. Solvents were reagent grade.
MATERIALS AND METHODS
Retinoids. All-trans-retinoic acid was obtained from Eastman. Radioinert all-trans-retinoyl glucuronide and all-trans- [11-3H] retinoyl glucuronide (0.7 mCi/mmol) were prepared chemically (22) . The following radioinert retinoid standards were gifts from Hoffmann-La Roche: all-trans-retinol, alltrans-retinyl acetate, all-trans-retinyl palmitate, all-trans-4-oxoretinoic acid, all-trans-5,6-epoxyretinoic acid, and 13-cisretinoic acid; 13-demethylretinoic acid was a gift from W. Lambert. All retinoids were stored under nitrogen at -70°C. Prior to use all-trans-retinoic acid and all-trans-retinoyl glucuronide were purified by HPLC on a semi-preparative (24) .
Preparation of Biological Materials for Analysis by HPLC. Cells were incubated with retinoids for either 1 hr, 24 hr, 48 hr, or 5 days. After incubation, cells and medium were treated with an equal volume of methanol, containing Npropyl gallate (50 ng/ml) and butylated hydroxytoluene (50 ng/ml), and then stored at -70°C. Samples were centrifuged to remove protein; aliquots of supernatants were analyzed for retinoids by HPLC and radioactivity. Recovery of radioactivity from all-trans-retinoyl glucuronide in the supernatant was 75-80%; extraction of the protein pellet with methanol resulted in 20-25% additional radioactivity; total radioactivity recovered was 100-105%.
Determination of Cell Proliferation and DNA Synthesis. (25) . At designated times, 2-5 x 105 cells were removed from the suspension culture, harvested by centrifuging, washed twice with 2 ml of Dulbecco's phosphate-buffered saline (PBS), resuspended in 1 ml of medium, and incubated for 1 hr at 37°C with 1 ,uCi of [3H]dThd (specific activity, 25 Ci/mmol). Following incubation, the cells were harvested and washed twice with 2 ml of PBS. The cell pellet was solubilized with 0.6 ml of 1 M NaOH, then neutralized with 1 M HCL. Acid-soluble material was precipitated with 2 ml of ice-cold 10% (wt/vol) trichloroacetic acid, and the precipitates were collected on glass-fiber filters and washed twice with 2 ml of ice-cold trichloroacetic acid and once with (27) . P-D-Glucuronidase was assayed as described by Dutton (28 j3-Glucuronidase Activity. 3-Glucuronidase activity, measured at its optimum at pH 4.5 (29), was not detected in the ,umol ofphenolphthalein liberated per min at 370C) (30) ; at pH 7.0, the activity was 0.4 x 1O-3 unit/mg ofprotein or 0.12 that of the activity at pH 4.5. Cytotoxicity. When HL-60 cells were exposed to 0.1 mM all-trans-retinoyl glucuronide or all-trans-retinoic acid for 1 hr and examined at 24 and 48 hr, all-trans-retinoyl glucuronide was found to be 50% less cytotoxic than all-transretinoic acid; a similar effect was observed after continuous 24-and 48-hr exposures of cells to 0.2 mM of either of these retinoids.
DISCUSSION
Retinoyl glucuronide is a biologically active metabolite of vitamin A (31, 32) . While this metabolite had been thought to Cells were exposed to 1 ,uM all-trans-retinoyl glucuronide for 2, 4, or 6 days during normal culture conditions. Following treatment, the medium containing all-trans-retinoyl glucuronide was replaced with fresh medium lacking all-trans-retinoyl glucuronide, and the cells were allowed to continue to grow for a total of 6 days (including growth during treatment). The number of cells was counted at 2, 4, and 6 days of incubation.
*Growth stimulation, 3-18%. be solely a product of vitamin A catabolism (33) , its discovery in vitamin A target tissues (23, 34) suggests that this very polar vitamin A active compound, because of its amphipathic properties, may also serve in other, physiologically important roles. Our present studies show that all-trans-retinoyl glucuronide inhibits HL-60 cell proliferation and induces HL-60 cell differentiation into functionally mature granulocytes to an extent equivalent to that of equimolar amounts of alltrans-retinoic acid. HPLC analysis of the retinoid metabolite profile during incubation of HL-60 cells with 3H-labeled all-trans-retinoyl glucuronide for 1 hr or for 24 hr revealed that the major (95%) labeled retinoid at all times was all-trans-retinoyl glucuronide; retinoic acid was not detected among the minor (5%) radioactive products; some retinoic acid, however, was formed artifactually during the extraction and evaporation procedures. Since we also observed f-Dglucuronidase activity in HL-60 cells, it is possible that some free all-trans-retinoic acid could be eventually generated from all-trans-retinoyl glucuronide, particularly during longer incubation periods. However, the activity of this enzyme in HL-60 cells was very low at the pH maintained during culture conditions. The presence of saccharo-1,4-lactone, an inhibitor of -D-glucuronidase, during the incubation did not alter metabolism of all-trans-retinoyl glucuronide. ,3D-Glucuronidase activity was not detected in the medium. Clearly, during our incubation conditions all-trans-retinoyl glucuronide was not hydrolyzed to a measurable amount of all-transretinoic acid. Although it appears that the observed biological activity can be ascribed solely to all-trans-retinoyl glucuronide, we cannot rule out the possibility that the activity of retinoyl glucuronide is the result of it being slowly hydrolyzed to retinoic acid, which is then immediately utilized and metabolized.
Previous studies have indicated that a continuous 48-hr exposure to all-trans-retinoic acid is required for onset of growth inhibition or for induction of optimal differentiation (7). We, however, observed a maximum differentiation of 50% of HL-60 cells to granulocytes at 48 hr whether the cells had been exposed to the retinoids for only 1 hr or continuously for 24 or 48 hr. Similarly, either a 1-hr or a 24-hr exposure of HL-60 cells to all-trans-retinoic acid or all-transretinoyl glucuronide resulted in 60-70% arrest of cell proliferation measured at 48 hr; this was similar to that observed after the cells had been exposed to the retinoids continuously for 48 hr. These effects were not reversible: the removal of all-trans-retinoic acid or all-trans-retinoyl glucuronide from the medium after a 1-hr treatment did not result in resumption Biochemistry: Zile et Our studies also briefly addressed the clinically important question of retinoid toxicity. We examined the viability of HL-60 cells in the presence of high (0.1 mM) equimolar concentrations of all-trans-retinoic acid and all-trans-retinoyl glucuronide. Our data demonstrate that all-trans-retinoyl glucuronide is 50% less cytotoxic to HL-60 cells than alltrans-retinoic acid (data not shown). Clinically, all-transretinoyl glucuronide may be a more useful retinoid than free all-trans-retinoic acid because of the greater amphipathic potential of the glucuronide and because of its lower toxicity.
The induction of differentiation in HL-60 cells by a brief exposure to all-trans-retinoyl glucuronide should facilitate the elucidation of the initial biochemical events that affect the genome and that subsequently result in phenotypic and morphological changes. It remains to be determined whether the expression of the tissue transglutaminase gene, which dramatically increased within 30 min of all-trans-retinoic acid administration (13) , is linked to the all-trans-retinoic acid-(and all-trans-retinoyl glucuronide)-induced arrest of HL-60 cell proliferation and induction of differentiation. The mechanism of action of retinoids on growth and differentiation is not understood. The absence in the HL-60 cells of the cellular all-trans-retinoic acid binding protein that has been demonstrated in many cells (11, 12) implies that retinoids in these cells act either by a different mechanism or that the all-transretinoic acid receptor has not yet been identified. This latter view appears to be more in harmony with the present concepts of growth regulation.
While the present work was in progress, we learned that similar studies were being conducted by J. M. Gallup, A.B.B., H. C. Furr, and J. A. Olson; their results appear to be in general agreement with the results reported here.
